Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 3, 2018
UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
RA’ANANA, Israel and NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
April 2, 2018
TherapeuticsMD Announces Expansion of Board of Directors
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced the appointment of Jane F. Barlow, M.D., M.B.A., M.P.H. as an independent ...
April 2, 2018
STRATA Skin Sciences Reports Fourth Quarter and Fiscal Year 2017 Financial Results
HORSHAM, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
April 2, 2018
STRATA Skin Sciences Announces $17 Million Equity Financing led by Accelmed Growth Partners; Appointment of Industry Veteran as Interim CEO
HORSHAM, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
April 2, 2018
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
April 2, 2018
Eiger BioPharmaceuticals to Participate in Conferences in April
PALO ALTO, Calif., April 2, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
April 2, 2018
ARMO BioSciences Reports FY 2017 Financial Results
REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) --  ARMO BioSciences, Inc. (ARMO), a late-stage immuno-oncology company, today announced its financial results for the fiscal ...
April 2, 2018
BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially
BOTHELL, Wash., April 2, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic ...
April 2, 2018
Albireo to Present at H.C. Wainwright Global Life Sciences Conference
BOSTON, April 02, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
April 2, 2018
Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pembrolizumab) Combination Trials
AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 2, 2018
Data Highlighting Advaxis’ ADXS-PSA Accepted as Poster Presentation at the American Society of Clinical Oncology Annual Meeting
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that The American Society of Clinical ...
March 28, 2018
TRACON Pharmaceuticals Announces $38.7 Million Private Placement
SAN DIEGO, March 23, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
March 28, 2018
Kiadis Pharma on track with European regulatory review for ATIR101
Amsterdam, The Netherlands, March 28, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing ...
March 28, 2018
BrainStorm Cell Therapeutics' Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients
NEW YORK and PETACH TIKVAH, Israel, March 28, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for ...
March 28, 2018
Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will present clinical and pre-clinical data on the company’s investigational medicines for the treatment of ...
March 28, 2018
Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference
BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD ...
March 28, 2018
BIOPHYTIS: 2017 Full Year Results
PARIS, March 28, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates for the treatment of ...
March 28, 2018
Aptose Biosciences Establishes New At-the-Market Facility
SAN DIEGO and TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
March 28, 2018
Albireo to Present Clinical Data on A4250 at The International Liver Congress™ 2018
BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 28, 2018
Arcturus Therapeutics Issues Open Letter to Shareholders
SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today issued the following open letter to shareholders ...
Page 53 of 117